ANGIODYNAMICS INC (ANGO) Stock News

AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI

Top movers in Wednesday's session

Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Crude Oil Down 1%; US Weekly Jobless Claims Decline

The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Let's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday

AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System

AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event

Notable Monday Option Activity: X, ANGO, CVNA

AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System

AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver

AngioDynamics is Now Oversold (ANGO)

Why AngioDynamics Stock Is Crashing Today

Investors didn't like the medical technology company's fiscal 2025 Q1 update.

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes

AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

AngioDynamics to Participate in Upcoming Investor Conferences

ANGO Stock Earnings: AngioDynamics Beats EPS, Beats Revenue for Q4 2024

ANGO stock results show that AngioDynamics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.